The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
WEANING OF IMMUNOSUPPRESSION IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS1
Abstract
BACKGROUND: Some reported studies have indicated the possibility of immunosuppression withdrawal in cadaveric liver transplantation. The aim of this study was to evaluate the possibility and feasibility of weaning living donor liver transplant recipients from immunosuppression. METHODS: From June of 1990 to October of 1999, 63 patients were considered to be weaned from immunosuppression. They consisted of 26 electively weaned patients and 37 either forcibly or incidentally weaned patients (nonelective weaning) due to various causes but mainly due to infection. Regarding elective weaning, we gradually reduced the frequency of tacrolimus administration for patients who survived more than 2 years after transplantation, maintained a good graft function, and had no rejection episodes in the preceding 12 months. The frequency of administration was reduced from the conventional b.i.d. until the start of weaning to q.d., 4 times a week, 3 times a week, twice a week, once a week, twice a month, once a month, and finally, the patients were completely weaned off with each weaning period lasting from 3 to 6 months. The reduction method of nonelective weaning depended on the clinical course of each individual case. When the patients were clinically diagnosed to develop rejection during weaning, then such patients were treated by a reintroduction of tacrolimus or an additional steroid bolus when indicated. RESULTS: Twenty-four patients (38.1%) achieved a complete withdrawal of tacrolimus with a median drug-free period of 23.5 months (range, 3-69 months). Twenty-three patients (36.5%) are still being weaned at various stages. Sixteen patients (25.4%) encountered rejection while weaning at median period of 9.5 months (range, 1-63 months) from the start of weaning. All 16 were easily treated with the reintroduction of tacrolimus or additional steroid bolus therapy. CONCLUSIONS: We were able to achieve a complete withdrawal of immunosuppression in some selected patients. Although the mechanism of graft acceptance in these patients has yet to be elucidated, we believe that a majority of long-term patients undergoing living donor liver transplantation may, thus, be potential candidates to be successfully weaned from immunosuppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
Cell migration, chimerism, and graft acceptance
Starzl, T. E., Murase, N., Ildstad, S., Ricordi, C., Demetris, A. J., & Trucco, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91840-5 · Cited by 1,051
Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., & Masucci, M. G. (1995) · Nature · doi:10.1038/375685a0 · Cited by 823
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
Starzl, T. E., Demetris, A. J., Trucco, M., Murase, N., Ricordi, C., Ildstad, S., Ramos, H., Todo, S., Tzakis, A., Fung, J. J., et al. (1993) · Hepatology · doi:10.1002/hep.1840170629 · Cited by 810
WEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS12
Mazariegos, G. V., Reyes, J., Marino, I. R., Demetris, A. J., Flynn, B., Irish, W., McMichael, J., Fung, J. J., & Starzl, T. E. (1997) · Transplantation · doi:10.1097/00007890-199701270-00012 · Cited by 411
RIGHT LOBE GRAFT IN LIVING DONOR LIVER TRANSPLANTATION 1,2
Inomata, Y., Uemoto, S., Asonuma, K., Egawa, H., Kiuchi, T., Fujita, S., Hayashi, M., Kawashima, M., & Tanaka, K. (2000) · Transplantation · doi:10.1097/00007890-200001270-00011 · Cited by 372
Self-citationQian, S., Lu, L., Fu, F., Li, Y., Li, W., Starzl, T. E., Fung, J. J., & Thomson, A. W. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4654 · Cited by 302
Antigen Localization and Migration in Immunity and Tolerance
Starzl, T. E., & Zinkernagel, R. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812243392607 · Cited by 275
Weaning Of Immunosuppression In Long-Term Liver Transplant Recipients
Ramos, H. C., Reyes, J., Abu-Elmagd, K., Zeevi, A., Reinsmoen, N., Tzakis, A., Demetris, A. J., Fung, J. J., Flynn, B., McMichael, J., et al. (1995) · Transplantation · doi:10.1097/00007890-199501270-00010 · Cited by 238
Defining the outcome of immunosuppression withdrawal after liver transplantation
Devlin, J., Doherty, D., Thomson, L., Wong, T., Donaldson, P., Portmann, B., & Williams, R. (1998) · Hepatology · doi:10.1002/hep.510270406 · Cited by 238
Cited by
Regulatory T cells in transplantation tolerance
Wood, K. J., & Sakaguchi, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri1027 · Cited by 1,317
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Identification of a B cell signature associated with renal transplant tolerance in humans
Newell, K. A., Asare, A., Kirk, A. D., Gisler, T. D., Bourcier, K., Suthanthiran, M., Burlingham, W. J., Marks, W. H., Sanz, I., Lechler, R. I., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39933 · Cited by 678
Todo, S., Yamashita, K., Goto, R., Zaitsu, M., Nagatsu, A., Oura, T., Watanabe, M., Aoyagi, T., Suzuki, T., Shimamura, T., et al. (2016) · Hepatology · doi:10.1002/hep.28459 · Cited by 441
Regulatory immune cells in transplantation
Wood, K. J., Bushell, A., & Hester, J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3227 · Cited by 431
Metadata
- Authors
- Takatsuki, M., Uemoto, S., Inomata, Y., Egawa, H., Kiuchi, T., Fujita, S., Hayashi, M., Kanematsu, T., & Tanaka, K.
- Venue
- Transplantation
- Published
- 2001-08
- Volume
- 72
- Issue
- 3
- Pages
- 449-454
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2058311698
- Cited by
- 296
- References
- 17
- FWCI
- 13.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: WEANING OF IMMUNOSUPPRESSION IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS1. https://app.cochat.ai/papers/10.1097/00007890-200108150-00016
- The paper
- Takatsuki, M., Uemoto, S., Inomata, Y., Egawa, H., Kiuchi, T., Fujita, S., Hayashi, M., Kanematsu, T., & Tanaka, K. (2001). WEANING OF IMMUNOSUPPRESSION IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS1. Transplantation. https://doi.org/10.1097/00007890-200108150-00016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.